Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Clinical Study to Assess the Long-term Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension

ClinicalTrials.gov ID: NCT00667823

Public ClinicalTrials.gov record NCT00667823. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 3:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Long-term Single-arm Open-label Extension Study of the SERAPHIN Study, to Assess the Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main objective of the AC 055 303/SERAPHIN OL study, which will follow the AC 055 302/SERAPHIN study, will be to assess the long-term safety and tolerability of ACT 064992 in patients with symptomatic PAH.

Study identification

NCT ID
NCT00667823
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Actelion
Industry
Enrollment
550 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 17, 2008 (Actual)
Primary completion
Dec 7, 2020 (Actual)
Completion
Dec 7, 2020 (Actual)
Last update posted
Mar 30, 2025

2008 – 2020

United States locations

U.S. sites
39
U.S. states
27
U.S. cities
35
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35249-0001 —
Arizona Pulmonary Specialists Phoenix Arizona 85012 —
University of California, San Diego La Jolla California 92037 —
GLVA Healthcare Center Los Angeles California 90073 —
Santa Barbara Cottage Hospital Santa Barbara California 93105 —
Liu Center for Pulmonary Hypertension Torrance California 90502-2006 —
University of Colorado CARDIAC AND VASCULAR CENTER Aurora Colorado 80045-2548 —
University of Florida - Division of Pulmonology Gainesville Florida 32610 —
Mayo Clinic, Jacksonville Jacksonville Florida 32259 —
Emory University Hospital - McKelvey Center for Lung Transplantation & Pulmonary Vascular Disease Atlanta Georgia 30322 —
Pulmonary & Critical Care of Atlanta Atlanta Georgia 30342-1713 —
Atlanta Institute for Medical Research Decatur Georgia 30030 —
University of Chicago Chicago Illinois 60637-1432 —
University of Iowa, Pulmonary Hypertension Program Iowa City Iowa 52242-1081 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Kentuckiana Pulmonary Associate, PLLC Louisville Kentucky 40202 —
Louisiana State University Health Sciences Center New Orleans Louisiana 70112-1393 —
Maine Medical Center Portland Maine 04102-3134 —
University of Maryland School of Medicine; Division of Cardiology Baltimore Maryland 21201-1544 —
Pulmonary/Critical Care Division/Tufts New England Medical Center Boston Massachusetts 02111-1552 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Boston University School of Medicine Boston Massachusetts 02118 —
University of Michigan Ann Arbor Michigan 48109 —
Harper Univ. Hospital/ Wayne State University Detroit Michigan 48201 —
Washington University School of Medicine St Louis Missouri 63110-1010 —
University of Nebraska Medical Center Omaha Nebraska 68198 —
University of NJ - Robert Wood Johnson Medical School New Brunswick New Jersey 08903-0010 —
Columbia University Medical Center - Pediatric Cardiology New York New York 10032 —
Duke University Medical Center Durham North Carolina 27710-0001 —
University of Cincinnati Ohio Heart Health Center Cincinnati Ohio 45219-2906 —
Ohio State University, Div. of Pul. & Critical Care Columbus Ohio 43210 —
Allegheny General Hospital Pittsburgh Pennsylvania 15212 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
University of Texas Medical Center - St. Paul University Dallas Texas 75390-8550 —
Baylor College of Medicine and the Methodist Hospital, Houston Texas 77030 —
University of Texas Houston Health Center Houston Texas 77030 —
Intermountain Med Ctr- Pulm Dept Heart and Lung Ctr Murray Utah 84157-5701 —
Sentara Hospitals T/A Sentara Cardiovascular Research Intitute Norfolk Virginia 23507-1904 —
Aurora St. Luke's Medical Center Milwaukee Wisconsin 53125 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 119 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00667823, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 30, 2025 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00667823 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →